The American Diabetes Association (ADA) guidelines recognize GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who require additional glucose-lowering therapy beyond metformin, particularly those with established cardiovascular disease or chronic kidney disease, with preference given to agents with proven cardiovascular benefit
Despite this, there were still post-operative symptoms related to underlying dysmotility only found on HRM
Sudlow, C
Similarly, food manufacturers should consider the potential for lifelong use of these medications, and what the nutritional requirements will be for those consumers
What is a Peptide Calculator
First, to ensure that the matching methodology was not a key driver of estimated treatment effects, we compared the results for modeling our primary outcomes for matched treatment and control groups selected through Coarsened Exact Matching (CEM), in addition to Propensity Score Matching
)
